Minerva Neurosciences
NERV
63 hedge funds and large institutions have $225M invested in Minerva Neurosciences in 2016 Q2 according to their latest regulatory filings, with 41 funds opening new positions, 16 increasing their positions, 5 reducing their positions, and 6 closing their positions.
583% more first-time investments, than exits
New positions opened: 41 | Existing positions closed: 6
220% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 5
197% more capital invested
Capital invested by funds: $75.6M → $225M (+$149M)
125% more funds holding
Funds holding: 28 → 63 (+35)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$17.6M |
| 2 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$8.32M |
| 3 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$7.95M |
| 4 |
Franklin Resources
San Mateo,
California
|
+$6.76M |
| 5 |
Millennium Management
New York
|
+$6.41M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DADC
D.A. Davidson & Co
Great Falls,
Montana
|
-$819K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$290K |
| 3 |
Goldman Sachs
New York
|
-$275K |
| 4 |
HCMT
Highland Capital Management (Texas)
Dallas,
Texas
|
-$165K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$126K |
NERV Hedge Fund Activity: Q2 2016 in Review
63 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Minerva Neurosciences (NERV) for Q2 2016, worth a combined $225M — up 197% from $75.6M a quarter earlier.
Buyers outnumbered sellers: 41 funds opened new NERV positions and 6 closed out — a net gain of 35 holders — while 16 added to existing stakes and 5 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $17.6M. The largest seller was D.A. Davidson & Co, exiting entirely with an estimated $819K sold.
- 63 institutional investors held Minerva Neurosciences (NERV) as of Q2 2016, up from 28 in Q1 2016.
- Funds reported $225M of Minerva Neurosciences stock for Q2 2016, up 197% quarter-over-quarter.
- 41 funds opened new Minerva Neurosciences positions in Q2 2016 and 6 closed out, a net change of +35 holders.
- The largest Minerva Neurosciences buyer in Q2 2016 was Fidelity Investments, an estimated $17.6M added.
- The largest Minerva Neurosciences seller in Q2 2016 was D.A. Davidson & Co, an estimated $819K sold.
Based on aggregated 13F filings for Q2 2016.